News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zeltiq Intellectual Property and Patents Validated in Settlement Against SkinSpaMed



8/27/2012 10:04:08 AM

PLEASANTON, Calif.--(BUSINESS WIRE)--ZELTIQ Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it has accepted a settlement from SkinSpaMed. In February of this year, the United States District Court for the Northern District of Texas, Dallas Division, granted ZELTIQ a preliminary injunction prohibiting SkinSpaMed from issuing false and misleading statements regarding its imitation “Fat Freeze Cryolipolysis” services.

Read at BioSpace.com


comments powered by Disqus
Zeltiq
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES